Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
- 1 January 1988
- Vol. 9 (3), 123-130
- https://doi.org/10.1016/8756-3282(88)90001-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.BMJ, 1987
- Effects of intravenous etidronate disodium on skeletal and calcium metabolismAmerican Journal Of Medicine, 1987
- Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.JCI Insight, 1986
- 68 Pathophysiology of hypercalcemia of malignancyJournal of Steroid Biochemistry, 1983
- Use of Dichloromethylene Diphosphonate in Metastatic Bone DiseaseNew England Journal of Medicine, 1983
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyAmerican Journal Of Medicine, 1982
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.JCI Insight, 1980
- The pathophysiology of hypercaemiaMetabolic Bone Disease and Related Research, 1980
- The assessment of phosphate reabsorptionClinica Chimica Acta; International Journal of Clinical Chemistry, 1969